Summary
Background
Orally ingested probiotic bacteria may modulate the immune response and increase antibody titers against enteric infections by bacteria or viruses. Even though positive effects of probiotics on respiratory tract infections have been reported, overall only few studies have examined effects on virus infections concerning organs other than the gastrointestinal tract.
Aim of the study
It was the aim of the study to investigate whether and how probiotics affect the immune response to a standardized enterovirus challenge (polio) and infections not limited to the gastrointestinal tract in healthy adults.
Methods
In a randomized, controlled and double–blind study 64 volunteers consumed for 5 weeks chemically acidified clotted milk without bacteria or with 1010/serving Lactobacillus rhamnosus GG or Lactobacillus acidophilus CRL431 added. In the second week subjects were vaccinated orally against polio 1, 2 and 3. Polio virus neutralizing serum activity, the primary parameter, was determined by the standard neutralization test (WHO) before and three times after vaccination. Polio–specific IgA, IgG and IgM were detected by ELISAs.
Results
Probiotics increased poliovirus neutralizing antibody titers (NT) and affected the formation of poliovirus–specific IgA and IgG in serum. The maximum increase after immunization was about 2, 2.2, or 4–fold higher, respectively, for NT, IgG or, IgA, in volunteers consuming probiotics instead of placebo. No consistent difference was noted between bacterial strains.
Conclusions
Probiotics induce an immunologic response that may provide enhanced systemic protection of cells from virus infections by increasing production of virus neutralizing antibodies.
Article PDF
Similar content being viewed by others
References
Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salminen S (2001) Probiotics: effects on immunity. Am J Clin Nutr 73:444S–450S
Blum S, Haller D, Pfeifer A, Schiffrin EJ (2002) Probiotics and immune response. Clin Rev Allergy Immunol 22:287–309
Cremonini F, Di Caro S, Nista EC, Bartolozzi F, Capelli G, Gasbarrini G, Gasbarrini A (2002) Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 16:1461–1467
Van Niel CW, Feudtner C, Garrison MM, Christakis DA (2002) Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109:678–684
Schrezenmeir J, de Vrese M (2001) Probiotics, prebiotics and synbiotics – approaching a definition. Am J Clin Nutr 73:361S–364S
Lykova EA, Vorob’ev AA, Bokovoi AG, Pobedinskaia IN, Gevondian VS, Gevondian NM, Mitrokhin SD, Minaev VI, Dzis NB, Makkaveeva LF, Kovalev IV, Murashova AO, Bondarenko VM (2000) Disruption of microbiocenosis of the large intestine and the immune and interferon status in children with bacterial complications of acute viral infections of the respiratory tract and their correction by high doses of bifidumbacterin forte (Article in Russian). Antibiot Khimioter 45:22–27
Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, Saxelin M, Korpela R (2001) Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322:1327–1329
Nibbeling R, Reimerink JHJ, Agboatwala M, Naquob T, Ras A, Poelstra P, van der Avoort HGAM, van Loon AM (1994) A poliovirus type-specific IgM antibody-capture enzyme-linked immunosorbent assay for the rapid diagnosis of poliomyelitis. Clinical and Diagnostic Virology 2:113–126
Faden H, Modlin JF, Thoms ML, Marshall McBean A, Ferdon MB, Ogra PL (1990) Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis 162:1291–1297
Emini EA, Jameson BA,Lewis AJ,Larsen GR,Wimmer E (1982) Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies. J Virol 43:997–1005
Ogra PL, Karzon DT (1971) Formation and function of poliovirus antibody in different tissues. Progress in Medical Virology (Fortschritte der medizinischen Virusforschung) 13:156–193
Sabin AB, Michaels RH, Ziring P, et al. (1963) Effect of oral poliovaccine in newborn children fed type 1 vaccine at birth. Pediatrics 31:641–650
World Health Organization (1992) Manual for the virological investigation of poliomyelitis,C-1211.Expanded Program on Immunization and Division of Communicable Diseases, World Health Organization, Geneva, Switzerland
Isenberg HD (1998) Essential procedures for clinical microbiology. ASM. Washington DC, pp 518–521
Edevag G, Wahren B, Osterhaus ADME, Sundqvist VA, Granstrom M (1995) Enzyme- linked immunosorbent assaybased inhibition test for neutralizing antibodies to polioviruses as an alternative to the neutralization test in tissue culture. J Clin Microbiol 33:2927–2930
Herremans MMPT, Reimerink JHJ, Ras A, van der Avoort HGAM, Kimman TG, van Loon AM, Conyn-van Spaendonck MAE, Koopmans MPG (1997) Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test. Clin Diagn Lab Immunol 4:659–664
Herremans MMPT, van Loon AM, Reimerink JHJ, Rümke HC, van der Avoort HGAM, Kimman TG, Koopmans MPG (1997) Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated vaccine in The Netherlands. Clin Diagn Lab Immunol 4:499–503
Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM (1994) Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 10:55–64
Sanders ME (1998) Overview of functional foods: Emphasis on probiotic bacteria. Int Dairy J 8:341–347
Reid G (1999) The scientific base for probiotic strains of Lactobacillus. Appl Environ Microbiol 65:3763–3766
Adam A, Petit JF, Lefrancier P, Lederer E (1981) Muramyl peptides. Mol Cell Biochem 41:27–47
Steward-Tull DES (1980) The immunological activities of bacterial peptidoglycans. Annu Rev Microbiol 34:311–340
Okutomi T, Inagawa H, Nishizawa T, Oshima H, Soma GI, Mizuno DI (1990) Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor. J Biol Resp Modifiers 9:564–569
Parant M, Parant F, Chedid L (1978) Enhancement of the neonates nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant. Proc Natl Acad Sci USA 75:3395–3399
Korhonen R, Korpela R, Moilanen E (2002) Signalling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoic acid. Inflammation 26:207–214
Matsuguchi T, Takagi A, Matsuzaki T, Nagaoka M, Ishikawa K, Yokokura T, Yoshikai Y (2003) Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Tolllike receptor 2. Clin Diagn Lab Immunol 10:259–266
Suzuki M, Hisamatsu T, Podolsky DK (2003) Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex. Infect Immun 71:3503–3511
Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS, Zhou Y, Hu B, Arditi M, Abreu MT (2003) Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 170:1406–1415
Matsuzaki, T Yamazaki, R Hashimoto, S Yokokura T (1998) The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J Dairy Sci 81:48–53
Author information
Authors and Affiliations
Corresponding author
Additional information
The work was supported by the German Academy of Nutritional Medicine, Freiburg, Germany; by MONA, division of Campina Melkunie, Woerden, The Netherlands and by Chr. Hansen, Hørsholm, Denmark.
Rights and permissions
About this article
Cite this article
de Vrese, M., Rautenberg, P., Laue, C. et al. Probiotic bacteria stimulate virus–specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr 44, 406–413 (2005). https://doi.org/10.1007/s00394-004-0541-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-004-0541-8